Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03462186 · ClinicalTrials.gov registry record · NA

Promoting Patient Engagement in Clinical Preventive Services: Evaluating the Use of Healthfinder

A NA study of Health Knowledge, Attitudes, Practice, sponsored by Virginia Commonwealth University.

Completed
Registry status
NA
Development phase
1,092
Enrollment target
1
Study location

NCT03462186: Completed NA study of Health Knowledge, Attitudes, Practice, sponsored by Virginia Commonwealth University.

NCT03462186 is a NA study of Health Knowledge, Attitudes, Practice that has completed, run by Virginia Commonwealth University. The registered enrollment target is 1,092 participants, below the 71,758-participant average among 28 other Health Knowledge, Attitudes, Practice trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03462186, a NA study of Health Knowledge, Attitudes, Practice, has completed, sponsored by Virginia Commonwealth University.

COMPLETED
Registry status
NA
Development phase
1,092 participants
Enrollment target
1
Study location

Study Summary

Clinical preventive services (CPS) are fundamental to early disease detection and improvement of health outcomes but are often poorly understood and utilized by patients. Myhealthfinder is a web-based tool developed by the Office of Disease Prevention and Health Promotion (https://healthfinder.gov). This study tests the "prescription" of myhealthfinder to engage patients in CPS, improve patient-clinician communication and increase uptake of CPS.

Primary Outcome

Percent up-to-datedness on cancer screening (cervical, breast, colon, lung cancer); immunizations (influenza, pneumonia) and cardiovascular disease (hypercholesterolemia, diabetes). This will be calculated based on the number of recommended services as identified on the healthfinder website based on age/gender that each patient has received within the recommended time frame.

Interventions

  • OTHER Healthfinder invitation

Study Locations (1)

Virginia

  • Virginia Commonwealth University - Richmond

Trial Details

FieldValue
Enrollment Target 1,092 participants
Start Date 2018-04-15
Est. Completion 2019-08-14
Phase NA
Virginia Commonwealth University

558 total trials

What the finished NCT03462186 record still lists

NCT03462186 is an interventional study that assigns participants to a tested intervention. Its 1,092 participants enrollment target places it among the larger protocols in the corpus, below the 71,758-participant average among 28 other Health Knowledge, Attitudes, Practice trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Health Knowledge, Attitudes, Practice appearing as the primary indexed condition, and to 1 intervention - of which Healthfinder invitation is the first listed.

NCT03462186 reports a single indexed study location in Virginia.

Frequently Asked Questions

What is clinical trial NCT03462186 about?

NCT03462186 is a clinical study titled "Promoting Patient Engagement in Clinical Preventive Services: Evaluating the Use of Healthfinder". Clinical preventive services (CPS) are fundamental to early disease detection and improvement of health outcomes but are often poorly understood and utilized by patients. Myhealthfinder is a web-based tool developed by the Office of Disease Prevention and Health Promotion (https://healthfinder.gov)....

What is the current status of trial NCT03462186?

This trial is currently completed. It is a NA study. The enrollment target is 1,092 participants. The study started on 2018-04-15. Estimated completion is 2019-08-14.

What conditions does trial NCT03462186 study?

This clinical trial studies the following conditions: Health Knowledge, Attitudes, Practice.

What interventions are being tested in trial NCT03462186?

The interventions under investigation include: Healthfinder invitation (OTHER).

Who is sponsoring clinical trial NCT03462186?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03462186 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Health Knowledge, Attitudes, Practice

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03462186's enrollment target sits among peer trials

1,092 4th of 28 higher than 25 of 28 other Health Knowledge, Attitudes, Practice trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Health Knowledge, Attitudes, Practice trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07196722 · 1,092 participants · Phase 2

    A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

  • NCT03754114 · 1,094 participants · NA

    Brain Oxygen Optimization in Severe TBI, Phase 3

  • NCT06118983 · 1,094 participants · NA

    Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF)

  • NCT06585241 · 1,094 participants · Phase 4

    A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03462186, the US trial registry maintained by the National Library of Medicine. NCT03462186 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.